Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

D Samuel Isaly


  • Large Shareholder at Xtant Medical Holdings Inc. (XTNT), 2018-01-19
  • Large Shareholder at Kala Pharmaceuticals Inc. (KALA), 2018-01-12
  • Large Shareholder at Pieris Pharmaceuticals Inc. (PIRS), 2018-01-04
  • Director at Loxo Oncology Inc. (LOXO), 2017-12-12
  • Large Shareholder at Scpharmaceuticals Inc. (SCPH), 2017-11-22
  • Large Shareholder at Arsanis Inc. (ASNS), 2017-11-20
  • Large Shareholder at Rhythm Pharmaceuticals Inc. (RYTM), 2017-10-10
  • Large Shareholder at Roka Bioscience Inc. (ROKA), 2017-10-05
  • Large Shareholder at Audentes Therapeutics Inc. (BOLD), 2017-09-29
  • Director at Glaukos Corp (GKOS), 2017-09-06
  • Director at Synlogic Inc. (SYBX), 2017-08-30
  • Large Shareholder, Director at Alpine Immune Sciences Inc. (ALPN), 2017-07-26
  • Large Shareholder at Cti Biopharma Corp (CTIC), 2017-06-15
  • Large Shareholder at Steadymed Ltd. (STDY), 2017-04-27
  • Director at Adaptimmune Therapeutics Plc (ADAP), 2017-03-28
  • Large Shareholder, Director at Aerpio Pharmaceuticals Inc. (NONE), 2017-03-18
  • Large Shareholder at Aeglea Biotherapeutics Inc. (AGLE), 2017-02-21
  • Large Shareholder, Director at Viewray Inc. (VRAY), 2017-01-20
  • Large Shareholder, Director at Nabriva Therapeutics Ag (NBRV), 2016-12-30
  • Large Shareholder, Director at Response Biomedical Corp (RBM), 2016-12-02
  • Large Shareholder at Relypsa Inc (RLYP), 2016-07-26
  • Large Shareholder, Director at Selecta Biosciences Inc (SELB), 2016-06-30
  • Large Shareholder, Director at Corvus Pharmaceuticals Inc. (CRVS), 2016-06-27
  • Director at Intellia Therapeutics Inc. (NTLA), 2016-05-13
  • Director at Otonomy Inc. (OTIC), 2015-11-30
  • Large Shareholder, Director at Dimension Therapeutics Inc. (DMTX), 2015-10-29
  • Large Shareholder at Sientra Inc. (SIEN), 2015-10-13
  • Director at Intercept Pharmaceuticals Inc (ICPT), 2015-07-22
  • Director at Pronai Therapeutics Inc (DNAI), 2015-07-21
  • Large Shareholder at Mirati Therapeutics Inc. (MRTX), 2015-02-05
  • Other at Acceleron Pharma Inc (XLRN), 2013-09-26
  • Large Shareholder at Ambit Biosciences Corp (AMBI), 2013-05-24
  • Large Shareholder at Supernus Pharmaceuticals Inc (SUPN), 2013-02-14
  • Director at Anthera Pharmaceuticals Inc (ANTH), 2013-02-02
  • Director at Amarin Corp Plc (AMRN), 2012-09-05
  • Large Shareholder at Complete Genomics Inc (GNOM), 2012-07-13
  • Large Shareholder at Pacira Pharmaceuticals Inc. (PCRX), 2012-03-13
  • Large Shareholder at Chemocentryx Inc. (CCXI), 2012-02-16
  • Large Shareholder at Athersys Inc / New (ATHX), 2011-04-30
  • Director at Nxstage Medical Inc. (NXTM), 2010-12-13
  • Large Shareholder at Kun Run Biotechnology Inc. (KURU.OB), 2010-05-10